Literature DB >> 29271065

Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4).

Christine Bookhout1, Thomas W Bouldin1, David W Ellison2.   

Abstract

Atypical teratoid/rhabdoid tumor (AT/RT) is a rare, highly aggressive malignancy of the central nervous system (CNS) usually diagnosed in infancy or childhood, most often characterized by loss of expression of the SMARCB1 gene product integrase interactor 1 (INI1) protein. We report a case of AT/RT in a 3 month old boy with retained expression of INI1 by immunohistochemistry. Additional testing demonstrated loss of expression of the SMARCA4 gene product Brahma-related gene 1 (BRG1) protein by immunohistochemistry, confirmed by next generation sequencing showing a nonsense mutation in SMARCA4. This case illustrates that positivity for INI1 does not rule out a diagnosis of AT/RT, and additional testing, including BRG1/SMARCA4 analysis, is warranted in cases where clinical suspicion is high.
© 2017 Japanese Society of Neuropathology.

Entities:  

Keywords:  BRG1; INI1; SMARCA4; SMARCB1; atypical teratoid/rhabdoid tumor

Mesh:

Substances:

Year:  2017        PMID: 29271065     DOI: 10.1111/neup.12452

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  6 in total

1.  Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors.

Authors:  Isabel Tegeder; Katharina Thiel; Serap Erkek; Pascal D Johann; Johannes Berlandi; Venu Thatikonda; Michael C Frühwald; Marcel Kool; Astrid Jeibmann; Martin Hasselblatt
Journal:  J Neurooncol       Date:  2018-11-16       Impact factor: 4.130

Review 2.  Recent Advances in Renal Medullary Carcinoma.

Authors:  Yongdong Su; Andrew L Hong
Journal:  Int J Mol Sci       Date:  2022-06-26       Impact factor: 6.208

Review 3.  BRM: the core ATPase subunit of SWI/SNF chromatin-remodelling complex-a tumour suppressor or tumour-promoting factor?

Authors:  Iga Jancewicz; Janusz A Siedlecki; Tomasz J Sarnowski; Elzbieta Sarnowska
Journal:  Epigenetics Chromatin       Date:  2019-11-13       Impact factor: 4.954

4.  Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.

Authors:  Dörthe Holdhof; Pascal D Johann; Michael Spohn; Michael Bockmayr; Sepehr Safaei; Piyush Joshi; Julien Masliah-Planchon; Ben Ho; Mamy Andrianteranagna; Franck Bourdeaut; Annie Huang; Marcel Kool; Santhosh A Upadhyaya; Anne E Bendel; Daniela Indenbirken; William D Foulkes; Jonathan W Bush; David Creytens; Uwe Kordes; Michael C Frühwald; Martin Hasselblatt; Ulrich Schüller
Journal:  Acta Neuropathol       Date:  2020-12-17       Impact factor: 17.088

5.  Clinical and prognostic analysis of 42 children with malignant rhabdoid tumor of the kidney: a 7-year retrospective multi-center study.

Authors:  Chenghao Zhanghuang; Zhaoxia Zhang; Li Zeng; Bing Yan; Haoyu Tang; Jinkui Wang; Xing Liu; Guanghui Wei; Dawei He
Journal:  BMC Pediatr       Date:  2022-10-13       Impact factor: 2.567

Review 6.  Atypical teratoid rhabdoid tumor: molecular insights and translation to novel therapeutics.

Authors:  Cody L Nesvick; Lucie Lafay-Cousin; Aditya Raghunathan; Eric Bouffet; Annie A Huang; David J Daniels
Journal:  J Neurooncol       Date:  2020-10-06       Impact factor: 4.130

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.